| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8293173 | Biochemical and Biophysical Research Communications | 2018 | 22 Pages |
Abstract
RK1 could open new perspective for the pharmaceutical application of short scorpion venom peptides in anticancer activity and may represent the first member of a new group of scorpion peptides.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Oussema Khamessi, Hazem Ben Mabrouk, Rym ElFessi-Magouri, Riadh Kharrat,